Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
12/17/2003 | EP1094794B1 Dry-copying method for producing flat, individually dosed preparations of active agents |
12/17/2003 | EP1079918B1 Microencapsulation and electrostatic processing method |
12/17/2003 | EP1032370B1 Porous hydroxyapatite particles as carriers for drug substances |
12/17/2003 | EP1028715B1 Dosage composition for nasal delivery comprising vibrio cholera zonula occludens toxin as absorption enhancer |
12/17/2003 | EP0980241B1 Gelatine encapsulated solution dosage forms of sertraline |
12/17/2003 | EP0974355B1 Water-soluble vitamin composition that provides excellent tablets and process for producing the same |
12/17/2003 | EP0939624B1 Effervescent bisphosphonate formulation |
12/17/2003 | EP0871430B1 Powders and their use in dry powder inhalers |
12/17/2003 | EP0852490B1 Emulsion formulations for the delivery of nucleic acids to cells |
12/17/2003 | EP0836495B1 Delivery of oxygen-supersaturated physiologic solutions |
12/17/2003 | EP0831820B1 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |
12/17/2003 | EP0806938B1 Powder for use in dry powder inhalers |
12/17/2003 | CN1462310A Process for producing isomaltose and use thereof |
12/17/2003 | CN1462194A Oral preparations and supports for oral preparations |
12/17/2003 | CN1462193A Oral preparations |
12/17/2003 | CN1462191A Treatment of ocute coronary syndrome with GLP-1 |
12/17/2003 | CN1462188A Compositions for regulating desire for smoking |
12/17/2003 | CN1462187A Analgesic/antiinflammatary patches for topical use |
12/17/2003 | CN1462186A Stable solid dosage forms of amino acids and processes for producing same |
12/17/2003 | CN1462185A Improved transdermal therapeutic system for treatment of Parkinson's disese |
12/17/2003 | CN1461639A Slow-releasing injection contg. hydrocastor oil/medicine (for treatment) solid dispersion microparticle |
12/17/2003 | CN1131271C Carrangeenan compositions and process for their production |
12/17/2003 | CN1131241C Cross-linked hyaluronic acids and medical uses thereof |
12/17/2003 | CN1131208C Compound, their preparation and use for transferring nucleic acids into cells |
12/17/2003 | CN1131072C Radioactive chitosan complex, its preparation method and use |
12/17/2003 | CN1131068C Composite lysostaphin enzyme spray for oral cavity and its preparing process |
12/17/2003 | CN1131066C Application of radix scutellariae stem and leaf for preparing medicine for analgesia, anti-flammatory/and antipyretic |
12/17/2003 | CN1131058C Chinese medicine for treating blood viscosity and its preparing process |
12/17/2003 | CN1131057C Chinese medicine fumigant for treating vulval disease and its prepn. method |
12/17/2003 | CN1131055C Tincture for treating leucoderma and preparation method and application thereof |
12/17/2003 | CN1131049C Medicine for treating psoriasis and preparation method thereof |
12/17/2003 | CN1131045C Aloe capsule prepared from natural aloe and its preparing process |
12/17/2003 | CN1131039C Process for preparing kelamycin injection |
12/17/2003 | CN1131034C Novel pharmaceutical composition |
12/17/2003 | CN1131033C Anaesthetic formulation |
12/17/2003 | CN1131032C Benzimidzole enteric coating preparation and preparing method thereof |
12/17/2003 | CN1131029C Application of dihydromyricetrin in medicine for preparation of hepatitis |
12/17/2003 | CN1131028C Once-a-day methoprolol oral dosage form |
12/17/2003 | CN1131027C Controlled release formulation for poorly soluble basic drugs |
12/17/2003 | CN1131026C Valaciclovir tablets containing colloidal silicon dioxide |
12/17/2003 | CN1131025C Granulate for preparation of fast-disintegrating and fast-dissolving compositions containing high amount of drug |
12/17/2003 | CN1131024C Sustained -release matrix pellets and its preparation |
12/17/2003 | CN1131023C Sustained release excipient |
12/17/2003 | CN1131018C Drug-containing adhesive composite transdermal administration plaster and preparation method thereof |
12/17/2003 | CN1130986C Health-care product for reducing blood fat and sugar and delaying sanility |
12/17/2003 | CN1130978C Rose fruit oil capsule |
12/16/2003 | US6665563 System and method for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment |
12/16/2003 | US6664296 Outer envelope including gelatin, and nonaqueous liquid or semi-liquid internal phase containing spermicide, lipophilic agent compatible with rubber latex of condom, gelling agent for lipophile, hydrodispersible agent and bioadhesion agent |
12/16/2003 | US6664294 Compounds which have excellent antimicrobial activity, even at very low concentrations, and which is retained in presence of salt-containing media, such as saline solutions |
12/16/2003 | US6664289 Nasal solution containing a broad spectrum microbicide and a method for its use |
12/16/2003 | US6664284 Stabilized carvedilol injection solution |
12/16/2003 | US6664105 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells |
12/16/2003 | US6663913 Method of coating a bioactive substance |
12/16/2003 | US6663901 Itraconazole; sugar core, a coating film of a water soluble polymer, a seal coating |
12/16/2003 | US6663900 Processed in a fluidized bed coating machine where a protective coating of a sugar or polyhydric alcohol, starch |
12/16/2003 | US6663899 Controlled release microencapsulated NGF formulation |
12/16/2003 | US6663898 Carbon-substituted diketopiperazine delivery systems |
12/16/2003 | US6663897 Oral itraconazole formulations and methods of making the same |
12/16/2003 | US6663896 Delayed release aspirin for vascular obstruction prophylaxis |
12/16/2003 | US6663895 Uniform crystal structure |
12/16/2003 | US6663894 Intraocular transplantation of encapsulated cells |
12/16/2003 | US6663893 Taste masking coating composition |
12/16/2003 | US6663892 Multiple portion tablet |
12/16/2003 | US6663891 Erythromyacin antibiotic product, use and formulation thereof |
12/16/2003 | US6663890 For therapy of bacterial infection; time-release agents |
12/16/2003 | US6663889 Ambroxol-containing lozenge |
12/16/2003 | US6663888 Mixture of two types of beads comprising a histamine H2 receptor antagonist, immediate release beads and timed pulsatile release beads; treatment of asthma, gastric acid secretion and cardiovascular diseases |
12/16/2003 | US6663887 Compounds and compositions for delivering active agents |
12/16/2003 | US6663886 Inhibition of cell-cell binding by lipid assemblies |
12/16/2003 | US6663885 Liposome system which comprises a non-toxic organic solvent and at least one phospholipid, which possesses a particularly high stability and does not lead to unwanted sedimentation. |
12/16/2003 | US6663883 Matrix adhering to nasal mucosa |
12/16/2003 | US6663881 Therapeutic inhibitor of vascular smooth muscle cells |
12/16/2003 | US6663878 Anti-inflammatory bioactive glass particulates |
12/16/2003 | US6663868 Heat shock protein-based vaccines and immunotherapies |
12/16/2003 | US6663849 Antacid chewing gum products coated with high viscosity materials |
12/16/2003 | US6663848 Process and apparatus for producing inhalable medicaments |
12/16/2003 | US6663615 Dual stage microvalve and method of use |
12/16/2003 | US6663608 Synchronizing of animal oestrus and intra vaginal devices useful therein |
12/16/2003 | US6663555 Permanent magnet keeper-shield assembly |
12/16/2003 | US6662805 Method for composite cell-based implants |
12/16/2003 | CA2382275C Modafinil having defined particle size |
12/16/2003 | CA2259297C Parenteral paclitaxel in a stable non-toxic formulation |
12/16/2003 | CA2124578C A mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses |
12/16/2003 | CA2110331C Desiccant, dehydration therewith, and dehydrated product obtainable thereby |
12/16/2003 | CA2074495C Propellant compositions |
12/14/2003 | CA2432231A1 Liquid antacid compositions |
12/11/2003 | WO2003102150A2 Multi-functional polyamines for delivery of biologically-active polynucleotides |
12/11/2003 | WO2003102116A2 Oil-soluble pigment compositions |
12/11/2003 | WO2003102014A2 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b |
12/11/2003 | WO2003101982A1 Nicotine-containing, controlled release composition and method |
12/11/2003 | WO2003101952A2 Polyamine-mediated transfection |
12/11/2003 | WO2003101606A1 Method of encapsulating hydrophobic organic molecules in polyurea capsules |
12/11/2003 | WO2003101600A2 Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous-aqueous emulsion |
12/11/2003 | WO2003101539A1 Self-administered contraceptive injection of oily solution |
12/11/2003 | WO2003101496A1 Methods and compositions for intravesical therapy of bladder cancer |
12/11/2003 | WO2003101493A1 Intravenous composition, process for producing the same and preparation thereof |
12/11/2003 | WO2003101486A2 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy |
12/11/2003 | WO2003101483A1 Pharmaceutical preparation of botulinum neurotoxin, methods of synthesis and methods of clinical use |
12/11/2003 | WO2003101480A1 Topical drug delivery using phosphatidylcholine |
12/11/2003 | WO2003101479A1 Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone |